An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Boaz Hirschberg, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Barranquilla, Atlántico, Colombia
- Research Site
Barranquilla, Colombia
- Research Site
Bogotá, Colombia
- Research Site
Curridabat, Provincia de San José, Costa Rica
- Research Site
Los Yoses, Provincia de San José, Costa Rica
- Research Site
Heredia, Costa Rica
- Research Site
México, D.f., Mexico
- Research Site
Durango, Durango, Mexico
- Research Site
Guadalajara, Jalisco, Mexico
- Research Site
Zapopan, Jalisco, Mexico
- Research Site
Cuernavaca, Morelos, Mexico
- Research Site
Querétaro City, Querétaro, Mexico
- Research Site
Lima, Peru
- Research Site
Jonesboro, Arkansas, United States
- Research Site
Anaheim, California, United States
- Research Site
Fountain Valley, California, United States
- Research Site
Los Angeles, California, United States
- Research Site
Pasadena, California, United States
- Research Site
Sacramento, California, United States
- Research Site
Gainesville, Florida, United States
- Research Site
Wellington, Florida, United States
- Research Site
Chicago, Illinois, United States
- Research Site
Springfield, Illinois, United States
- Research Site
Indianapolis, Indiana, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Salisbury, North Carolina, United States
- Research Site
Wilmington, North Carolina, United States
- Research Site
Winston-Salem, North Carolina, United States
- Research Site
Columbus, Ohio, United States
- Research Site
Marion, Ohio, United States
- Research Site
Simpsonville, South Carolina, United States
- Research Site
Bristol, Tennessee, United States
- Research Site
Alexandria, Virginia, United States
- Research Site
Burke, Virginia, United States
- Research Site
Manassas, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 31 Oct 2010
- Completion
- 31 Oct 2010
- Last update posted
- 27 Sept 2011
- Registered enrollment
- 282
- Registry id
- NCT00960076
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.